Logo image of MTAL

MAC COPPER LTD (MTAL) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MTAL - JE00BQBC8469 - Common Stock

12.21 USD
0 (0%)
Last: 10/10/2025, 8:45:28 PM
12.22 USD
+0.01 (+0.08%)
After Hours: 10/10/2025, 8:45:28 PM
Fundamental Rating

3

Overall MTAL gets a fundamental rating of 3 out of 10. We evaluated MTAL against 155 industry peers in the Metals & Mining industry. MTAL may be in some trouble as it scores bad on both profitability and health. MTAL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MTAL has reported negative net income.
MTAL had a positive operating cash flow in the past year.
MTAL had negative earnings in 4 of the past 5 years.
In the past 5 years MTAL reported 4 times negative operating cash flow.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of -6.05%, MTAL is not doing good in the industry: 64.10% of the companies in the same industry are doing better.
MTAL has a Return On Equity of -17.03%. This is in the lower half of the industry: MTAL underperforms 69.23% of its industry peers.
MTAL has a Return On Invested Capital of 5.65%. This is in the better half of the industry: MTAL outperforms 65.38% of its industry peers.
Industry RankSector Rank
ROA -6.05%
ROE -17.03%
ROIC 5.65%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

MTAL has a Operating Margin of 22.68%. This is in the better half of the industry: MTAL outperforms 75.00% of its industry peers.
With a decent Gross Margin value of 31.07%, MTAL is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
OM 22.68%
PM (TTM) N/A
GM 31.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTAL is destroying value.
MTAL has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MTAL has been reduced compared to a year ago.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

MTAL has an Altman-Z score of 0.70. This is a bad value and indicates that MTAL is not financially healthy and even has some risk of bankruptcy.
MTAL's Altman-Z score of 0.70 is on the low side compared to the rest of the industry. MTAL is outperformed by 83.33% of its industry peers.
The Debt to FCF ratio of MTAL is 7.26, which is on the high side as it means it would take MTAL, 7.26 years of fcf income to pay off all of its debts.
MTAL has a better Debt to FCF ratio (7.26) than 66.03% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that MTAL is somewhat dependend on debt financing.
MTAL's Debt to Equity ratio of 0.68 is on the low side compared to the rest of the industry. MTAL is outperformed by 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.26
Altman-Z 0.7
ROIC/WACC0.54
WACC10.47%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.58 indicates that MTAL may have some problems paying its short term obligations.
MTAL has a worse Current ratio (0.58) than 91.67% of its industry peers.
A Quick Ratio of 0.45 indicates that MTAL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.45, MTAL is doing worse than 90.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.45
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.56% over the past year.
MTAL shows a strong growth in Revenue. In the last year, the Revenue has grown by 114.30%.
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.27%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.39%

3.2 Future

The Earnings Per Share is expected to grow by 89.23% on average over the next years. This is a very strong growth
MTAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.12% yearly.
EPS Next Y270.09%
EPS Next 2Y183.08%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue Next Year6.2%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

MTAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MTAL is valuated reasonably with a Price/Forward Earnings ratio of 10.66.
83.97% of the companies in the same industry are more expensive than MTAL, based on the Price/Forward Earnings ratio.
MTAL is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 10.66
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

MTAL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MTAL is cheaper than 83.33% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MTAL indicates a rather cheap valuation: MTAL is cheaper than 86.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.49
EV/EBITDA 8.18
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

MTAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTAL's earnings are expected to grow with 104.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y183.08%
EPS Next 3Y104.94%

0

5. Dividend

5.1 Amount

No dividends for MTAL!.
Industry RankSector Rank
Dividend Yield N/A

MAC COPPER LTD

NYSE:MTAL (10/10/2025, 8:45:28 PM)

After market: 12.22 +0.01 (+0.08%)

12.21

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-20 2025-10-20/bmo
Inst Owners35.58%
Inst Owner Change-96.97%
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)340.74M
Net Income(TTM)-81.69M
Analysts77.78
Price Target12.5 (2.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.59%
EPS NY rev (1m)-51.89%
EPS NY rev (3m)-52.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.66
P/S 2.95
P/FCF 19.49
P/OCF 8.32
P/B 2.1
P/tB 2.1
EV/EBITDA 8.18
EPS(TTM)-0.99
EYN/A
EPS(NY)1.14
Fwd EY9.38%
FCF(TTM)0.63
FCFY5.13%
OCF(TTM)1.47
OCFY12.01%
SpS4.13
BVpS5.82
TBVpS5.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.05%
ROE -17.03%
ROCE 7.16%
ROIC 5.65%
ROICexc 6.28%
ROICexgc 6.28%
OM 22.68%
PM (TTM) N/A
GM 31.07%
FCFM 15.16%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.26
Debt/EBITDA 2.11
Cap/Depr 88.98%
Cap/Sales 20.34%
Interest Coverage 1.86
Cash Conversion 77.97%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.45
Altman-Z 0.7
F-Score6
WACC10.47%
ROIC/WACC0.54
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.27%
EPS Next Y270.09%
EPS Next 2Y183.08%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.39%
Revenue Next Year6.2%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%
EBIT growth 1Y660.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year134.05%
EBIT Next 3Y50.95%
EBIT Next 5Y38.1%
FCF growth 1Y770.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2321.04%
OCF growth 3YN/A
OCF growth 5YN/A

MAC COPPER LTD / MTAL FAQ

Can you provide the ChartMill fundamental rating for MAC COPPER LTD?

ChartMill assigns a fundamental rating of 3 / 10 to MTAL.


What is the valuation status for MTAL stock?

ChartMill assigns a valuation rating of 6 / 10 to MAC COPPER LTD (MTAL). This can be considered as Fairly Valued.


What is the profitability of MTAL stock?

MAC COPPER LTD (MTAL) has a profitability rating of 2 / 10.


What is the financial health of MAC COPPER LTD (MTAL) stock?

The financial health rating of MAC COPPER LTD (MTAL) is 2 / 10.